Artwork

Indhold leveret af Baptist Health. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Baptist Health eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Prostate Cancer Perspectives: Clinical Insights and Emerging Advances

37:01
 
Del
 

Manage episode 435109584 series 3393216
Indhold leveret af Baptist Health. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Baptist Health eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Aside from non-melanoma skin cancers, Prostate cancer, or PCa, is the most common cancer diagnosed for males in the United States and the second leading cause of cancer death for them. Its varying degrees of aggressiveness along with high incidence to mortality ratio, provide significant challenges for both patients and the medical community. However, the treatment landscape of PCa and its metastatic form is rapidly evolving and recent trials in patients with metastatic castration resistant prostate cancer are showing great promise.

Presenters:

Rohan Garje, M.D., Chief of Genitourinary Medical Oncology at Baptist Health Miami Cancer Institute

Adeel Kaiser, M.D., Board Certified Radiation Oncologist at Baptist Health Miami Cancer Institute

  continue reading

22 episoder

Artwork
iconDel
 
Manage episode 435109584 series 3393216
Indhold leveret af Baptist Health. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Baptist Health eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Aside from non-melanoma skin cancers, Prostate cancer, or PCa, is the most common cancer diagnosed for males in the United States and the second leading cause of cancer death for them. Its varying degrees of aggressiveness along with high incidence to mortality ratio, provide significant challenges for both patients and the medical community. However, the treatment landscape of PCa and its metastatic form is rapidly evolving and recent trials in patients with metastatic castration resistant prostate cancer are showing great promise.

Presenters:

Rohan Garje, M.D., Chief of Genitourinary Medical Oncology at Baptist Health Miami Cancer Institute

Adeel Kaiser, M.D., Board Certified Radiation Oncologist at Baptist Health Miami Cancer Institute

  continue reading

22 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning